Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bain

Showing results (251-260 of 494) with videos related to

Pageof 50
Sort By:
Frontiers in Endocrinology|August 21, 2019
Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 DiabetesOlivia McCarthy, Othmar Moser, Max L Eckstein, et al.
Diabetologia|April 11, 2003
Nitric oxide synthase gene polymorphisms and diabetic nephropathyJ D Rippin, A Patel, N D Belyaev, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2011
Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetesR M Bracken, D J West, J W Stephens, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 9, 2024
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6Stephen C Bain, Nicolas Belmar, Søren T Hoff, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|July 18, 2025
Conformational Heterogeneity Governs Charge Transfer Pathways in a Pentacene-Diketopyrrolopyrrole DyadAleesha George, David C Bain, Kanad Majumder, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 9, 2024
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational StudyDavid M Williams, Barbara-Alex Alberts, Asem Sharaf, et al.
Journal of Leukocyte Biology|April 3, 2018
An efficient method to isolate Kupffer cells eliminating endothelial cell contamination and selective biasRuairi W Lynch, Catherine A Hawley, Antonella Pellicoro, et al.
Diabetologia|September 24, 1999
The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patientsP H Dyer, T A Chowdhury, M J Dronsfield, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular riskMansoor Husain, Stephen C Bain, Ole K Jeppesen, et al.
European Journal of Endocrinology|March 28, 2002
Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathyGareth G Lavery, Claire L McTernan, Stephen C Bain, et al.
Pageof 50

Showing results (251-260 of 494) with videos related to

Sort By:
Pageof 50
Frontiers in Endocrinology|August 21, 2019
Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 DiabetesOlivia McCarthy, Othmar Moser, Max L Eckstein, et al.
Diabetologia|April 11, 2003
Nitric oxide synthase gene polymorphisms and diabetic nephropathyJ D Rippin, A Patel, N D Belyaev, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2011
Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetesR M Bracken, D J West, J W Stephens, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 9, 2024
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6Stephen C Bain, Nicolas Belmar, Søren T Hoff, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|July 18, 2025
Conformational Heterogeneity Governs Charge Transfer Pathways in a Pentacene-Diketopyrrolopyrrole DyadAleesha George, David C Bain, Kanad Majumder, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 9, 2024
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational StudyDavid M Williams, Barbara-Alex Alberts, Asem Sharaf, et al.
Journal of Leukocyte Biology|April 3, 2018
An efficient method to isolate Kupffer cells eliminating endothelial cell contamination and selective biasRuairi W Lynch, Catherine A Hawley, Antonella Pellicoro, et al.
Diabetologia|September 24, 1999
The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patientsP H Dyer, T A Chowdhury, M J Dronsfield, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular riskMansoor Husain, Stephen C Bain, Ole K Jeppesen, et al.
European Journal of Endocrinology|March 28, 2002
Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathyGareth G Lavery, Claire L McTernan, Stephen C Bain, et al.
Pageof 50